Acadia Healthcare Company, Inc. (ETR:7RA)
Germany · Delayed Price · Currency is EUR | Market Cap | 2.21B +21.2% |
| Revenue (ttm) | 2.92B +6.8% |
| Net Income | -960.14M |
| EPS | -10.62 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 18.18 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 21.20 |
| Previous Close | n/a |
| Day's Range | 21.20 - 21.20 |
| 52-Week Range | 21.00 - 22.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About Acadia Healthcare Company
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and i... [Read more]
News
Jefferies upgrades Acadia Healthcare to Buy on belief in new management
As previously reported, Jefferies upgraded Acadia Healthcare (ACHC) to Buy from Hold with a price target of $30, up from $24.50, citing a belief that new management is well-positioned to…
Acadia Healthcare upgraded to Buy from Hold at Jefferies
Jefferies analyst Brian Tanquilut upgraded Acadia Healthcare (ACHC) to Buy from Hold with a price target of $30, up from $24.50.
Acadia Healthcare price target raised to $31 from $28 at RBC Capital
RBC Capital raised the firm’s price target on Acadia Healthcare (ACHC) to $31 from $28 and keeps an Outperform rating on the shares after its Q1 earnings beat. Shares reversed…
Acadia Healthcare price target raised to $31 from $26 at Guggenheim
Guggenheim raised the firm’s price target on Acadia Healthcare (ACHC) to $31 from $26 and keeps a Buy rating on the shares, citing higher EBITDA estimates and execution “deserving of…
Acadia Healthcare upgraded to Strong Buy from Outperform at Raymond James
Raymond James upgraded Acadia Healthcare (ACHC) to Strong Buy from Outperform with a price target of $39, up from $25. The company reported a solid 1Q beat and modestly raised…
Acadia Healthcare price target raised to $30 from $20 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Acadia Healthcare (ACHC) to $30 from $20 and keeps a Neutral rating on the shares. Accelerating bad debt and denial trends, though…
Acadia Healthcare price target raised to $32 from $26 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Acadia Healthcare (ACHC) to $32 from $26 and keeps a Buy rating on the shares.
Acadia Healthcare price target raised to $25 from $20 at Barclays
Barclays raised the firm’s price target on Acadia Healthcare (ACHC) to $25 from $20 and keeps an Equal Weight rating on the shares.
Acadia Healthcare falls -16.1%
Acadia Healthcare (ACHC) is down -16.1%, or -$4.56 to $23.70.
Acadia Healthcare falls -19.6%
Acadia Healthcare (ACHC) is down -19.6%, or -$5.53 to $22.73.
Acadia Healthcare Company Earnings Call Transcript: Q1 2026
Revenue and Adjusted EBITDA exceeded guidance in Q1 2026, driven by strong acute and RTC performance. Full-year Adjusted EBITDA and EPS guidance were raised, while operational improvements and leadership changes support continued growth.
Acadia Healthcare Company Earnings release: Q1 2026
Acadia Healthcare Company released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Acadia Healthcare Company Slides: Q1 2026
Acadia Healthcare Company has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Acadia Healthcare Company Quarterly report: Q1 2026
Acadia Healthcare Company has published its Q1 2026 quarterly earnings report on April 30, 2026.
Acadia Healthcare price target raised to $25 from $20 at Barclays
Barclays raised the firm’s price target on Acadia Healthcare (ACHC) to $25 from $20 and keeps an Equal Weight rating on the shares. The firm updated the company’s model post…
Acadia Healthcare sees Q2 adjusted EPS 30c-40c, consensus 48c
16:19 EDT Acadia Healthcare (ACHC) sees Q2 adjusted EPS 30c-40c, consensus 48c
Acadia Healthcare Announces First Quarter 2026 Results
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter...
Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadi...
David Einhorn signals caution as his hedge fund Greenlight prioritizes capital protection
Greenlight Capital's David Einhorn warned that investors may be underestimating potential downside risks. "It probably won't surprise anyone that we are again putting capital preservation at the top o...
Acadia Healthcare Announces Date for First Quarter 2026 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its first quarter 2026 results on Wednesday, April 29, 2026, after the close of th...
Acadia Healthcare Company Proxy statement: Proxy filing
Acadia Healthcare Company filed a proxy statement on March 25, 2026, providing details for shareholder voting and corporate governance matters.
Acadia Healthcare Company Proxy statement: Proxy filing
Acadia Healthcare Company filed a proxy statement on March 25, 2026, providing details for shareholder voting and corporate governance matters.
Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia”) today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately. Mr. ...
Acadia Healthcare Company Transcript: Barclays 28th Annual Global Healthcare Conference
Leadership changes have energized operations, with a focus on filling 3,000 new beds and improving execution. Demand remains strong, but policy changes and payer scrutiny present headwinds. Expense management and capital deployment prioritize debt reduction and operational efficiency.
Acadia Healthcare Company Transcript: Leerink Global Healthcare Conference 2026
Leadership is driving organizational changes to improve execution and facility performance, with a focus on maximizing existing assets and reducing costs. Financial guidance is conservative, prioritizing debt reduction as CapEx declines, while risk management addresses rising malpractice claims and payer challenges.